First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

  1. Di Leo, A.
  2. Jerusalem, G.
  3. Torres, R.
  4. Verhoeven, D.
  5. Pendergrass, K.
  6. Malorni, L.
  7. Lichfield, J.
  8. Martin, M.
Aldizkaria:
Breast

ISSN: 1532-3080,  0960-9776

Argitalpen urtea: 2018

Alea: 38

Orrialdeak: 144-149

Mota: Artikulua

DOI: 10.1016/J.BREAST.2017.12.016 GOOGLE SCHOLAR
Datuen iturria: Scopus